Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARCH THERAPEUTICS INC

SummaryChartsNewsRatingsCompany 
Business Summary
Arch Therapeutics, Inc. is a development-stage company. The Company operates as a biotechnology company. The Company focuses on developing products to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. The Company's technology is based on a self-assembling peptide that creates a physical, mechanical barrier, which could be applied to seal organs or wounds that are leaking blood and other fluids. The Company's primary product candidates, collectively known as the AC5 Devices (AC5), are designed to achieve hemostasis in surgical procedures. The Company's product candidates rely on its self-assembling peptide technology and are designed to achieve hemostasis in skin wounds, and minimally invasive and open surgical procedures. The Company focuses on developing other product candidates based on its technology platform for use in a range of indications. As of September 30, 2016, the Company had not generated any revenues.

Number of employees : 7 people.
Managers
Name Title Age Since
Terrence W. Norchi, Dr. Chairman, President & Chief Executive Officer 55 2018
Michael S. Abrams Chief Financial Officer & Treasurer 51 2021
James R. Sulat Independent Director 69 2015
Punit S. Dhillon Independent Director 40 2018
Dan Yrigoyen Vice President-Sales - 2021
Daniel C. Wadsworth Vice President-Dermal Sciences 65 -
Members of the board
Name Title Age Since
Terrence W. Norchi, Dr. Chairman, President & Chief Executive Officer 55 2018
James R. Sulat Independent Director 69 2015
Punit S. Dhillon Independent Director 40 2018
Laurence Hicks Director - 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 236,719,770 204,597,996 86.4% 0 0.0% 86.4%
Shareholders
NameEquities%
Michael Andrew Parker 15,467,830 6.53%
Terrence W. Norchi 13,559,076 5.73%
James R. Sulat 1,679,009 0.71%
Richard E. Davis 878,000 0.37%
Dan Yrigoyen 150,000 0.063%
CapFinancial Partners LLC 54,500 0.023%
Laurence Hicks 27,273 0.012%
PanAgora Asset Management, Inc. 26,115 0.011%
Cribstone Capital Management LLC 25,288 0.011%
The Bryn Mawr Trust Co. (Investment Management) 15,000 0.0063%
Company contact information
Arch Therapeutics, Inc.
235 Walnut Street
Suite 6
Framingham, MA 01702

Phone : +1.617.431.2313
Web : http://www.archtherapeutics.com